Strategic Imperatives in a Shifting GLP-1 Market The GLP-1 market has exposed how quickly alternative channels like telehealth platforms and compounding pharmacies can scale and disrupt traditional brand management
This promotes a feeling of fullness and may help with weight management
Arch Physiol Biochem
In most trial participants, these symptoms were transient and mild to moderate in severity , often resolving or diminishing as the body adjusted over the first four to eight weeks
[2] Since then, several other GLP-1 agonists have been developed and approved for clinical use, including liraglutide (Victoza), dulaglutide (Trulicity), semaglutide (Ozempic and Wegovy), and Tirzepatide (Mounjaro and Zepbound)
329, Issue 6, Dec 1, 2025, pp